ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 35 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +1.4% | 51,849 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $70 | -41.7% | 50,849 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $120 | +3.4% | 50,849 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $116 | -99.9% | 50,849 | -0.6% | 0.01% | -25.0% |
| Q3 2022 | $141,000 | +12.8% | 51,149 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $125,000 | -38.1% | 51,149 | 0.0% | 0.01% | -22.2% |
| Q1 2022 | $202,000 | -10.6% | 51,149 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $226,000 | -28.5% | 51,149 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $316,000 | -22.0% | 51,149 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $405,000 | -26.0% | 51,149 | 0.0% | 0.02% | -30.8% |
| Q1 2021 | $547,000 | – | 51,149 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |